Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 33, 2024 - Issue 5
Submit an article Journal homepage
497
Views
0
CrossRef citations to date
0
Altmetric
Plain Language Summary

Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus

Eric F. Morand1 Monash University
,
Marilyn Pike2 Med-Pharm Consulting, Inc
,
J Merrill3 Oklahoma Medical Research Foundation
,
Ronald F van Vollenhoven4 Amsterdam University Medical Centres
,
Victoria P Werth5 University of Pennsylvania and the Michael J. Crescenz VA Medical Center
,
Coburn Hobar6 Bristol Myers Squibb
,
Nikolay Delev6 Bristol Myers Squibb
,
Vaishali Shah6 Bristol Myers Squibb
,
Brian Sharkey6 Bristol Myers Squibb
,
Thomas Wegman6 Bristol Myers Squibb
,
Ian Catlett6 Bristol Myers Squibb
,
Subhashis Banerjee6 Bristol Myers Squibb
&
Shalabh Singhal6 Bristol Myers Squibb
 show all
Pages 431-440 | Received 07 Feb 2024, Accepted 28 Mar 2024, Published online: 29 May 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Translations

Translations of this plain language summary are available for download:

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.